FDA Inspection 1096365 — Fmg Co., Ltd.

Fmg Co., Ltd. — FEI 3012217889

The FDA completed an inspection of Fmg Co., Ltd. on Jul 12, 2019 in Chuncheon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 9 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 12, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chuncheon (Korea (the Republic of))

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
150421 CFR 211.122(d)Labels and labeling stored separately
172421 CFR 211.134(b)Representative samples after completion
188521 CFR 211.165(b)Microbiological testing
197621 CFR 211.182Specific information required in individual logs
202021 CFR 211.188(b)(8)Labeling Control Records and Label Copies
202721 CFR 211.192Investigations of discrepancies, failures
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.